GS
MIRO

Gagnon Securities’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Gagnon Securities’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,458,351
Closed -$1.91M – 107
2023
Q3 		$1.91M Buy
1,458,351
+16,937
+1% +$24.7K 0.48% 42
2023
Q2 		$2.52M Buy
1,441,414
+4,712
+0.3% +$6.21K 0.52% 38
2023
Q1 		$2.41M Buy
1,436,702
+589,770
+70% +$1.53M 0.51% 39
2022
Q4 		$2.53M Buy
846,932
+54,988
+7% +$216K 0.56% 35
2022
Q3 		$3.47M Sell
791,944
-99,381
-11% -$321K 0.76% 36
2022
Q2 		$3.56M Buy
891,325
+42,212
+5% +$162K 0.75% 35
2022
Q1 		$3.36M Buy
849,113
+440,726
+108% +$1.64M 0.55% 39
2021
Q4 		$1.92M Sell
408,387
-15,162
-4% -$108K 0.29% 44
2021
Q3 		$2.95M Sell
423,549
-12,360
-3% -$117K 0.44% 42
2021
Q2 		$5.08M Buy
+435,909
New +$5.61M 0.72% 38

Gagnon Securities's MIRO Position: Q4 2023 in Review

Gagnon Securities sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 1,458,351 shares — an estimated $1.91M sold.

Gagnon Securities first reported a position in MIRO in Q2 2021 and held it in 10 quarters. The position peaked at $5.08M in Q2 2021. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • Gagnon Securities reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Gagnon Securities sold 1,458,351 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $1.91M.
  • Gagnon Securities first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Gagnon Securities's Miromatrix Medical Inc. Common Stock position peaked at $5.08M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Gagnon Securities's 13F filing for Q4 2023, filed 14 Feb 2024.